BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33096054)

  • 1. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
    Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
    Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma.
    Millet A; Khoudour N; Lebert D; Machon C; Terrier B; Blanchet B; Guitton J
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
    Jourdil JF; Lebert D; Gautier-Veyret E; Lemaitre F; Bonaz B; Picard G; Tonini J; Stanke-Labesque F
    Anal Bioanal Chem; 2017 Feb; 409(5):1195-1205. PubMed ID: 27826630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
    Willeman T; Jourdil JF; Gautier-Veyret E; Bonaz B; Stanke-Labesque F
    Anal Chim Acta; 2019 Aug; 1067():63-70. PubMed ID: 31047150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches.
    Legeron R; Xuereb F; Chaignepain S; Gadeau AP; Claverol S; Dupuy JW; Djabarouti S; Couffinhal T; Schmitter JM; Breilh D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():43-53. PubMed ID: 29111437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
    Jourdil JF; Némoz B; Gautier-Veyret E; Romero C; Stanke-Labesque F
    Ther Drug Monit; 2018 Aug; 40(4):417-424. PubMed ID: 29608486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
    Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
    Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Quantification of Free Adalimumab and Infliximab in Human Plasma Using a Target-Based Sample Purification and Liquid Chromatography-Tandem Mass Spectrometry.
    El Amrani M; Bosman SM; Egas AC; Hack CE; Huitema ADR; van Maarseveen EM
    Ther Drug Monit; 2019 Oct; 41(5):640-647. PubMed ID: 31584927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay.
    Iwamoto N; Takanashi M; Shimada T; Sasaki J; Hamada A
    AAPS J; 2019 Aug; 21(6):101. PubMed ID: 31432293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods.
    Tron C; Lemaitre F; Bros P; Goulvestre C; Franck B; Mouton N; Bagnos S; Coriat R; Khoudour N; Lebert D; Blanchet B
    Bioanalysis; 2022 Jun; 14(11):831-844. PubMed ID: 35735172
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipients.
    Truffot A; Jourdil JF; Veyret-Gautier E; Noble J; Jouve T; Malvezzi P; Rostaing L; Stanke-Labesque F
    Clin Biochem; 2023 Mar; 113():17-20. PubMed ID: 36586569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography-tandem mass spectrometry assay.
    Kuhn J; Götting C; Kleesiek K
    J Pharm Biomed Anal; 2010 Jan; 51(1):210-6. PubMed ID: 19720490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A generic sample preparation method for the multiplex analysis of seven therapeutic monoclonal antibodies in human plasma or serum with liquid chromatography-tandem mass spectrometry.
    Amrani ME; Gerencser L; Huitema ADR; Hack CE; van Luin M; van der Elst KCM
    J Chromatogr A; 2021 Oct; 1655():462489. PubMed ID: 34509691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
    Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method.
    El Amrani M; van den Broek MP; Göbel C; van Maarseveen EM
    J Chromatogr A; 2016 Jul; 1454():42-8. PubMed ID: 27264745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A versatile method for protein-based antigen bioanalysis in non-clinical pharmacokinetics studies of a human monoclonal antibody drug by an immunoaffinity liquid chromatography-tandem mass spectrometry.
    Onami I; Ayabe M; Murao N; Ishigai M
    J Chromatogr A; 2014 Mar; 1334():64-71. PubMed ID: 24572547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood.
    Steuer AE; Poetzsch M; Koenig M; Tingelhoff E; Staeheli SN; Roemmelt AT; Kraemer T
    J Chromatogr A; 2015 Feb; 1381():87-100. PubMed ID: 25596763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An LC-MS/MS Method for Absolute Quantification of Nivolumab in Human Plasma: Application to Clinical Therapeutic Drug Monitoring.
    Irie K; Okada A; Yamasaki Y; Kokan C; Hata A; Kaji R; Fukushima K; Sugioka N; Okada Y; Katakami N; Fukushima S
    Ther Drug Monit; 2018 Dec; 40(6):716-724. PubMed ID: 30048380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.